1. Home
  2. CNTB vs BRID Comparison

CNTB vs BRID Comparison

Compare CNTB & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • BRID
  • Stock Information
  • Founded
  • CNTB 2012
  • BRID 1932
  • Country
  • CNTB United States
  • BRID United States
  • Employees
  • CNTB N/A
  • BRID N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • BRID Specialty Foods
  • Sector
  • CNTB Health Care
  • BRID Consumer Staples
  • Exchange
  • CNTB Nasdaq
  • BRID Nasdaq
  • Market Cap
  • CNTB 90.3M
  • BRID 72.8M
  • IPO Year
  • CNTB 2021
  • BRID N/A
  • Fundamental
  • Price
  • CNTB N/A
  • BRID $8.25
  • Analyst Decision
  • CNTB Strong Buy
  • BRID
  • Analyst Count
  • CNTB 2
  • BRID 0
  • Target Price
  • CNTB $7.50
  • BRID N/A
  • AVG Volume (30 Days)
  • CNTB 88.0K
  • BRID 3.5K
  • Earning Date
  • CNTB 11-13-2025
  • BRID 08-22-2025
  • Dividend Yield
  • CNTB N/A
  • BRID N/A
  • EPS Growth
  • CNTB N/A
  • BRID N/A
  • EPS
  • CNTB N/A
  • BRID N/A
  • Revenue
  • CNTB $1,965,000.00
  • BRID $227,364,000.00
  • Revenue This Year
  • CNTB N/A
  • BRID N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • BRID N/A
  • P/E Ratio
  • CNTB N/A
  • BRID N/A
  • Revenue Growth
  • CNTB N/A
  • BRID N/A
  • 52 Week Low
  • CNTB $1.23
  • BRID $7.35
  • 52 Week High
  • CNTB $2.20
  • BRID $10.83
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 58.99
  • BRID 61.53
  • Support Level
  • CNTB $1.36
  • BRID $7.93
  • Resistance Level
  • CNTB $1.88
  • BRID $8.13
  • Average True Range (ATR)
  • CNTB 0.15
  • BRID 0.08
  • MACD
  • CNTB 0.04
  • BRID 0.01
  • Stochastic Oscillator
  • CNTB 99.48
  • BRID 100.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: